Actin Antibody IgG

Overview

  • EPIC Code:
  • IMO206
  • Soft Test Code:
  • SMA1
  • Send Out Test Code:
  • 15043
Alternate Names
  • 15043X
  • ACTA
  • Actin (Smooth Muscle) Antibody (IgG)
  • Anti-Smooth Muscle Ab
  • Anti-Smooth Muscle Antibody
  • Anti-smooth muscle Antibody Titer
  • ASMA
  • ASMA IGF
  • F-Actin Antibody
  • SM Muscle Actin Ab
  • SMA
  • Smooth Muscle (Actin) Antibody
  • Smooth Muscle Antibody
Clinical Significance

 Actin is the major antigen to which smooth muscle antibodies react in autoimmune hepatitis. F-Actin IGG antibodies are found in 52-85% of patients with Autoimmune Hepatitis (AIH) or chronic active hepatitis and in 22% of patients with Primary Biliary Cirrhosis (PBC). Anti-Actin antibodies have been reported in 3-18% of sera from normal healthy controls.


Specimen Collection & Preparation

Specimen Requirements:

-OR-

1.0 mL Serum from a Red Top Tube in a Plastic Vial
Minimum Volume:
0.25 mL Serum*

* This volume does not allow for repeat testing

Rejection Criteria:

Gross hemolysis

Lipemia

Microbially contaminated serum

Specimens containing heavy, visible particulate


Transport and Storage:
  • Ambient (18-24°C): 14 Days
  • Refrigerated (2-8°C): 14 Days
  • Frozen (-20° C or colder): 30 Days

Clinical Interpretation

Reference Range:

<20 U Negative
> 20 U Positive


Test Comments:

Antibodies recognizing actin are the main component of smooth muscle antibodies associated with autoimmune liver disease. Actin antibodies are found in approximately 75% of patients with autoimmune hepatitis (AIH) type 1, approximately 65% of patients with autoimmune cholangitis, approximately 30% of patients with primary biliary cirrhosis, and approximately 2% of healthy people. High values are closely correlated with AIH type 1.


Methodology:
  • Enzyme Linked Immunosorbent Immunoassay (ELISA)

Clinical Significance

 Actin is the major antigen to which smooth muscle antibodies react in autoimmune hepatitis. F-Actin IGG antibodies are found in 52-85% of patients with Autoimmune Hepatitis (AIH) or chronic active hepatitis and in 22% of patients with Primary Biliary Cirrhosis (PBC). Anti-Actin antibodies have been reported in 3-18% of sera from normal healthy controls.


Production Schedule

Sites Performed
  • Quest - Chantilly
Days Performed
Monday
Tuesday
Wednesday
Thursday
Friday
Departments
  • Sendouts - Clinical
Turn Around Time

3 to 5 days


Coding & Compliance

CDM

00917148


CPT Coding

86015